Michael A Nauck Selected Research

Michael A Nauck Research Topics

Disease

117	Type 2 Diabetes Mellitus (MODY) 04/2024 - 03/2002
25	Body Weight (Weight, Body) 01/2024 - 04/2002
16	Weight Loss (Weight Reduction) 10/2023 - 09/2003
16	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 03/2002
14	Myocardial Infarction 01/2024 - 10/2005
10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 08/2015
9	Pancreatitis 01/2020 - 07/2013
9	Weight Gain 09/2017 - 04/2002
8	Stroke (Strokes) 01/2024 - 01/2016
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2013
8	Obesity 01/2023 - 04/2002
8	Nausea 01/2022 - 06/2005
7	Heart Failure 12/2022 - 01/2016
7	Insulin Resistance 01/2022 - 06/2008
6	Hyperglycemia 10/2023 - 12/2004
6	Vomiting 01/2022 - 06/2005
5	Glucose Intolerance 05/2020 - 11/2003
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 07/2013
4	Neoplasms (Cancer) 01/2020 - 05/2007
3	Inflammation (Inflammations) 01/2022 - 03/2004
3	Diabetes Mellitus 01/2020 - 09/2009
3	Chronic Pancreatitis 01/2020 - 07/2013
3	Acute Coronary Syndrome 01/2018 - 07/2002
2	Albuminuria 01/2023 - 01/2022
2	Constipation 01/2022 - 10/2020
2	Chronic Renal Insufficiency 01/2022 - 03/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 08/2015
2	COVID-19 01/2021 - 12/2020
2	Peripheral Arterial Disease 01/2019 - 01/2018
2	Injection Site Reaction 02/2016 - 04/2014
2	Critical Illness (Critically Ill) 01/2015 - 03/2004
2	Infections 01/2014 - 09/2011
2	Urinary Tract Infections (Urinary Tract Infection) 01/2014 - 09/2011
1	Chronic Disease (Chronic Diseases) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Fatty Liver 01/2022
1	Diabetes Complications 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Diarrhea 10/2020
1	Dyspepsia (Indigestion) 10/2020
1	Amyloid Plaque 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020

Drug/Important Bio-Agent (IBA)

66	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 03/2002
55	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2024 - 03/2002
45	Insulin (Novolin)FDA Link 10/2023 - 05/2003
34	IncretinsIBA 10/2023 - 03/2004
29	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024 - 05/2006
29	Liraglutide FDA Link 01/2022 - 06/2005
17	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 10/2014
17	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 07/2009
16	Hormones (Hormone)IBA 10/2023 - 03/2002
12	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2023 - 11/2006
11	Peptides (Polypeptides)IBA 10/2023 - 04/2004
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 06/2008
10	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2022 - 01/2003
10	semaglutideIBA 01/2022 - 02/2016
10	Sitagliptin Phosphate (Januvia)FDA Link 12/2020 - 11/2006
9	tirzepatideIBA 01/2024 - 11/2018
9	Exenatide (Byetta)FDA Link 01/2021 - 06/2005
8	Glucagon (Glukagon)FDA Link 01/2022 - 03/2002
7	Blood Glucose (Blood Sugar)IBA 01/2024 - 03/2004
6	dulaglutideIBA 01/2024 - 01/2017
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024 - 09/2011
5	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2019
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 03/2004
5	lixisenatideIBA 01/2020 - 01/2017
5	Insulin Glargine (Lantus)FDA Link 01/2020 - 07/2010
5	VildagliptinIBA 11/2016 - 11/2006
4	Sodium-Glucose Transport ProteinsIBA 01/2024 - 09/2011
4	rGLP-1 proteinIBA 12/2019 - 04/2014
4	C-PeptideIBA 02/2016 - 05/2003
4	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2016 - 03/2004
3	SodiumIBA 01/2023 - 01/2021
3	Amylases FDA Link 01/2017 - 11/2003
2	gastric inhibitory polypeptide receptorIBA 10/2023 - 12/2004
2	glimepiride (Amarel)FDA LinkGeneric 01/2023 - 09/2017
2	LipidsIBA 01/2023 - 12/2004
2	AcidsIBA 11/2022 - 01/2020
2	CarbohydratesIBA 02/2022 - 01/2017
2	octanoic acid (caprylic acid)IBA 01/2021 - 06/2003
2	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2020 - 01/2006
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2020 - 11/2016
2	Lipase (Acid Lipase)FDA Link 01/2017 - 11/2014
2	EnzymesIBA 01/2017 - 07/2010
2	Therapeutic UsesIBA 01/2016 - 07/2002
2	taspoglutideIBA 09/2013 - 07/2009
2	ProinsulinIBA 12/2012 - 10/2010
1	LC15-0444IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	LinagliptinIBA 01/2022
1	CreatinineIBA 01/2020

Therapy/Procedure

37	Therapeutics 04/2024 - 04/2004
7	Glycemic Control 10/2023 - 06/2008
5	Injections 01/2023 - 06/2005
3	Bariatric Surgery 01/2023 - 01/2016
3	Aftercare (After-Treatment) 01/2022 - 04/2011
3	Intravenous Infusions 01/2017 - 12/2003
2	Drug Therapy (Chemotherapy) 05/2007 - 04/2002
1	Subcutaneous Injections 01/2024